1,385 research outputs found
Towards a Theory of Legal Animal Rights: Simple and Fundamental Rights
With legal animal rights on the horizon, there is a need for a more systematic theorisation of animal rights as legal rights. This article addresses conceptual, doctrinal and normative issues relating to the nature and foundations of legal animal rights by examining three key questions: can, do and should animals have legal rights? It will show that animals are conceptually possible candidates for rights ascriptions. Moreover, certain ‘animal welfare rights’ could arguably be extracted from existing animal welfare laws, even though these are currently imperfect and weak legal rights at best. Finally, this article introduces the new conceptual vocabulary of simple and fundamental animal rights, in order to distinguish the weak legal rights that animals may be said to have as a matter of positive law from the kind of strong legal rights that animals ought to have as a matter of future law
COMPARISON OF THE VALIDITY AND RELIABILITY OF SELF-REPORTED ARTICULAR INDICES
Our objective was to compare the validity and reliability of three formats for self-administered articular indices assessing pain (PAI) or swelling (SAI). Fifty-five patients with rheumatoid arthritis were asked to mark the degree of pain on a list of 16 joints (PAI list), to mark ‘painful joints' on a mannequin presenting 42 joints (PAI diagram), and to mark ‘swollen or tender joints' on a mannequin presenting 38 joints (SAI diagram). The test-retest reliability (intraclass correlation coefficient) ranged from 0.63 (SAI diagram) to 0.67 (PAI diagram) and 0.85 (PAI list). The correlation with clinical parameters was strongest for the PAI list and the SAI diagram. The association of the SAI diagram with clinical parameters increased with omission of the less reliable toe joints and/or weighting for joint size according to Lansbury. As expected, the short and weighted SAI diagram correlated more strongly with the physician-derived swollen joint count (r = 0.49), C-reactive protein (r = 0.49) and erythrocyte sedimentation rate (r = 0.41) than did the PAI list whereas the PAI list correlated more strongly with physician-derived tender joint count (r = 0.43), global pain measured on a numerical rating scale (r = 0.57) and the Health Assessment Questionnaire (r = 0.49) than did the SAI diagram. We concluded that patients' rating of tender and swollen joints on a mannequin diagram and calculation of a 26-joint and weighted articular index produces an excellent estimate of total joint inflammation, which may be useful in clinical, health services and epidemiological research. An articular index calculated from ratings of pain degree of 16 joints or joint groups may provide complementary informatio
Responsiveness of the International Classification of Functioning, Disability and Health (ICF) Core Set for rheumatoid arthritis
Background: The comprehensive International
Classification of Functioning, Disability and Health (ICF)
Core Set for rheumatoid arthritis (RA) is a selection of 96
categories from the ICF, representing relevant aspects in
the functioning of patients with RA.
Objectives: To study the responsiveness of the ICF Core
Set for RA in rheumatological practice.
Methods: A total of 46 patients with RA (72% women,
mean (SD) age 53.6 (12.6) years, disease duration 6.3
(8.0) years) were interviewed at baseline and again after
6 months treatment with a disease-modifying antirheumatic
drug (DMARD), applying the ICF Core Set for RA
with qualifiers for problems on a modified three-point
scale (no problem, mild/moderate, severe/complete).
Patient-reported outcomes included Modified Health
Assessment Questionnaire (MHAQ) and Short-Form 36
(SF-36) health survey, and disease activity was calculated.
Responsiveness was measured as change in
qualifiers in ICF categories, and was also compared with
change in patient-reported outcomes.
Results: After 6 months of DMARD treatment,
improvement by at least one qualifier was seen in 20% of
patients (averaged across all ICF categories), 71%
experienced no change and 9% experienced worsening
symptoms. Findings were similar across the different
aspects of functioning. Mainly moderate effect sizes were
seen for 6-month changes in the ICF Core Set for RA,
especially in patients with improved health status, with
similar effect size for disease activity. The components in
the ICF Core Set for RA were only weakly associated with
patient-reported outcomes and disease activity.
Conclusions: The ICF Core Set for RA demonstrated
moderate responsiveness in this real-life setting of
patients where minor changes occurred during treatment
with DMARDs
High rate, long-distance quantum key distribution over 250km of ultra low loss fibres
We present a fully automated quantum key distribution prototype running at
625 MHz clock rate. Taking advantage of ultra low loss fibres and low-noise
superconducting detectors, we can distribute 6,000 secret bits per second over
100 km and 15 bits per second over 250km
From Bruges to Venice 1: Towards a common structure for international physical and rehabilitation medicine congresses
Electrodialytic processes in solid matrices. New insights into batteries recycling. A review.
Electrodialytic Remediation has been widely applied to the recovery of different contaminants from numerous solid matrices solving emerging issues of environmental concern. Results and conclusions reported in studies about real contaminated matrices are summarizes in this work. The influence of the pH value on the treatment effectiveness has been widely proved highlighting the phenomenon “water splitting” in the membrane surface. This dissociation of water molecules is related to the “limiting current” which is desirable to be exceed at the Anion Exchange Membrane in order to produce the entering of protons toward solid matrix. Other important parameters for the optimization of the technique, such as the current density and the liquid to solid ratio, are also discussed through the revision of studies using real solid matrices.
This work also focusses on the pioneer proposal of electrokinetic technologies for the recycling of lithium ion batteries considering the relevance of waste properties in the design and optimization of the technique. From a thorough literature revision, it could be concluded that further experimental results are needed to allow an optimal application of the technique to the rising problem of residues from batteries. The main aim of this work is to take the first steps in the recovery of valuable metals from spent batteries, such as Li and Co, incorporating principles of green chemistry.The authors acknowledge the financial support from the “Plan Propio de Investigación de la Universidad de Málaga with Project numbers: PPIT.UMA.B1.2017/20 and PPIT.UMA.B5.2018/17 and the European project THROUGH H2020-MSCA-RISE- 2017-778045. The first author also acknowledge the postdoctoral contract obtained from University of Malaga
Gene identification for the cblD defect of vitamin B12 metabolism
Background Vitamin B12 (cobalamin) is an essential cofactor in several metabolic pathways. Intracellular conversion of cobalamin to its two coenzymes, adenosylcobalamin in mitochondria and methylcobalamin in the cytoplasm, is necessary for the homeostasis of methylmalonic acid and homocysteine. Nine defects of intracellular cobalamin metabolism have been defined by means of somatic complementation analysis. One of these defects, the cblD defect, can cause isolated methylmalonic aciduria, isolated homocystinuria, or both. Affected persons present with multisystem clinical abnormalities, including developmental, hematologic, neurologic, and metabolic findings. The gene responsible for the cblD defect has not been identified.
Methods We studied seven patients with the cblD defect, and skin fibroblasts from each were investigated in cell culture. Microcell-mediated chromosome transfer and refined genetic mapping were used to localize the responsible gene. This gene was transfected into cblD fibroblasts to test for the rescue of adenosylcobalamin and methylcobalamin synthesis.
Results The cblD gene was localized to human chromosome 2q23.2, and a candidate gene, designated MMADHC (methylmalonic aciduria, cblD type, and homocystinuria), was identified in this region. Transfection of wild-type MMADHC rescued the cellular phenotype, and the functional importance of mutant alleles was shown by means of transfection with mutant constructs. The predicted MMADHC protein has sequence homology with a bacterial ATP-binding cassette transporter and contains a putative cobalamin binding motif and a putative mitochondrial targeting sequence.
Conclusions Mutations in a gene we designated MMADHC are responsible for the cblD defect in vitamin B12 metabolism. Various mutations are associated with each of the three biochemical phenotypes of the disorder
Developing core sets for persons following amputation based on the International Classification of Functioning, Disability and Health as a way to specify functioning
Amputation is a common late stage sequel of peripheral vascular disease and diabetes or a sequel of accidental trauma, civil unrest and landmines. The functional impairments affect many facets of life including but not limited to: Mobility; activities of daily living; body image and sexuality. Classification, measurement and comparison of the consequences of amputations has been impeded by the limited availability of internationally, multiculturally standardized instruments in the amputee setting. The introduction of the International Classification of Functioning, Disability and Health (ICF) by the World Health Assembly in May 2001 provides a globally accepted framework and classification system to describe, assess and compare function and disability. In order to facilitate the use of the ICF in everyday clinical practice and research, ICF core sets have been developed that focus on specific aspects of function typically associated with a particular disability. The objective of this paper is to outline the development process for the ICF core sets for persons following amputation. The ICF core sets are designed to translate the benefits of the ICF into clinical routine. The ICF core sets will be defined at a Consensus conference which will integrate evidence from preparatory studies, namely: (a) a systematic literature review regarding the outcome measures of clinical trails and observational studies, (b) semi-structured patient interviews, (c) international experts participating in an internet-based survey, and (d) cross-sectional, multi-center studies for clinical applicability. To validate the ICF core sets field-testing will follow. Invitation for participation: The development of ICF Core Sets is an inclusive and open process. Anyone who wishes to actively participate in this process is invited to do so
Effects of creatine supplementation on muscle weakness in patients with rheumatoid arthritis
Background and objectives. Patients with rheumatoid arthritis (RA) frequently suffer from muscle weakness. Oral administration of creatine has been shown to improve muscle strength in healthy subjects. The objective of this study was to examine the effect of oral creatine supplementation on muscle weakness, disease activity and activities of daily living in patients with RA. Methods. During a period of 3 weeks, 12 patients with RA were treated with creatine monohydrate (20 g/day for 5 days followed by 2 g/day for 16 days). They were examined on entry and at the end of the study. The patients were investigated clinically, blood and urine samples were obtained, muscle biopsies were performed before and after treatment, muscle strength was determined, and self‐administered patient questionnaires were completed. Results. From all patients we were able to obtain full clinical and questionnaire data, while biopsies were taken from 12 patients at the start and from nine patients at the end of the study. Muscle strength, as determined by the muscle strength index, increased in eight of 12 patients. In contrast, physical functional ability and disease activity did not change significantly. The creatine concentration in serum and skeletal muscle increased significantly, while creatine phosphate and total creatine did not increase in skeletal muscle. The skeletal muscle creatine content was associated with muscle strength at baseline but not after administration of creatine. The changes in muscle strength were not associated with the changes in skeletal muscle creatine or creatine phosphate. Conclusion. Although the skeletal muscle creatine content and muscle strength increased with creatine administration in some patients with RA, a clear clinical benefit could not be demonstrated for this treatment when the patients were considered as one grou
- …